HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong-Wei Zhao Selected Research

Proteins (Proteins, Gene)

8/2020High-mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
5/2019Eukaryotic translation initiation factor 5A2 is highly expressed in prostate cancer and predicts poor prognosis.
6/2016Chelerythrine chloride induces apoptosis in renal cancer HEK-293 and SW-839 cell lines.
6/2016[Effects of Qizhi Jiangtang capsule on protein expressions of InsR, PI3K, GLUT2 and p-JNK in hepatic tissues of rats with type 2 diabetes].
1/2016[Effects of Qizhi Jiangtang capsule on dermal ulcer in type 2 diabetic rats].
12/2008Antiapoptotic mechanisms of Chinese medicine formula, Guan-Xin-Er-Hao, in the rat ischemic heart.
1/2008Adenoviral vector mediates high expression levels of human lactoferrin in the milk of rabbits.
5/2007High-level expression of human lactoferrin in the milk of goats by using replication-defective adenoviral vectors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong-Wei Zhao Research Topics

Disease

15Neoplasms (Cancer)
06/2022 - 02/2008
6Hepatic Encephalopathy
02/2021 - 09/2014
5Portal Hypertension
06/2022 - 09/2014
5Infections
09/2014 - 05/2007
4Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 06/2010
4Thrombosis (Thrombus)
06/2022 - 11/2015
4Hemorrhage
01/2020 - 09/2014
3Myocardial Infarction
01/2023 - 12/2008
2Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 10/2015
2Fibrosis (Cirrhosis)
02/2021 - 07/2016
2Liver Diseases (Liver Disease)
08/2020 - 05/2009
2Prostatic Neoplasms (Prostate Cancer)
07/2020 - 05/2019
2Pathologic Constriction (Stenosis)
04/2019 - 09/2014
2Ischemia
01/2018 - 05/2009
2Ascites
11/2015 - 09/2014
2Hepatocellular Carcinoma (Hepatoma)
11/2015 - 05/2009
1Non-ST Elevated Myocardial Infarction
01/2024
1Acute Coronary Syndrome
01/2024
1Margins of Excision
12/2023
1Diabetic Retinopathy (Retinopathy, Diabetic)
12/2022
1Vitreous Hemorrhage
12/2022
1Non-alcoholic Fatty Liver Disease
01/2022
1End Stage Liver Disease
02/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021
1Coinfection
01/2021
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
12/2020
1Pneumonia (Pneumonitis)
10/2020
1Multiple Organ Failure (MODS)
10/2020
1Atrial Fibrillation
10/2020
1Pain (Aches)
10/2020
1Urethral Stricture
08/2020
1Urinary Retention
08/2020
1Hepatorenal Syndrome
08/2020
1Abscess
08/2020
1Diabetes Mellitus
01/2020
1No-Reflow Phenomenon
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Carcinoma (Carcinomatosis)
01/2019
1Epilepsy (Aura)
11/2018
1Reperfusion Injury
01/2018

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
08/2020 - 05/2007
3ParaffinIBA
05/2019 - 12/2013
3Caspase 3 (Caspase-3)IBA
01/2018 - 12/2008
3Capsules (Microcapsules)IBA
08/2016 - 01/2016
2Indicators and Reagents (Reagents)IBA
01/2024 - 01/2023
2LDL CholesterolIBA
01/2023 - 01/2020
2Glucose (Dextrose)FDA LinkGeneric
01/2023 - 06/2016
2Therapeutic UsesIBA
08/2020 - 01/2020
2Iodine-125IBA
04/2019 - 12/2018
2Saline SolutionIBA
01/2018 - 05/2009
2Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2009 - 05/2009
2DNA (Deoxyribonucleic Acid)IBA
05/2009 - 05/2009
2antineoplaston A10 (A 10)IBA
01/2008 - 05/2007
1Cytidine Triphosphate (CTP)IBA
12/2023
1Triglycerides (Triacylglycerol)IBA
01/2023
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
12/2022
1AntioxidantsIBA
01/2022
1EnzymesIBA
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
01/2021
1IodineIBA
10/2020
1Amiodarone (Amiodarona)FDA LinkGeneric
10/2020
1DexmedetomidineFDA Link
10/2020
1Biomarkers (Surrogate Marker)IBA
08/2020
1HMGB1 Protein (HMG1)IBA
08/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1oxidized low density lipoproteinIBA
01/2020
1cordycepinIBA
01/2020
1C-Reactive ProteinIBA
01/2020
1TicagrelorIBA
01/2020
1Messenger RNA (mRNA)IBA
05/2019
1Peptide Initiation Factors (Initiation Factor)IBA
05/2019
1bivalirudin (Angiomax)FDA Link
01/2019
1Complement System Proteins (Complement)IBA
01/2019
1Heparin (Liquaemin)FDA LinkGeneric
01/2019
1Levetiracetam (Keppra)FDA LinkGeneric
11/2018
1N- (2- hydroxy- 3- (2- cyano- 3- chlorophenoxy)propyl)- 1,1- dimethyl- 2- (2- nephthyl)ethylamineIBA
01/2018

Therapy/Procedure

9Surgical Portasystemic Shunt (Portosystemic Shunt)
06/2022 - 09/2014
7Transjugular Intrahepatic Portasystemic Shunt
02/2021 - 09/2014
4Percutaneous Coronary Intervention
01/2024 - 01/2019
4Stents
04/2019 - 09/2014
3Therapeutics
01/2023 - 11/2018
3Nephrectomy
06/2022 - 06/2010
2Prostatectomy (Retropubic Prostatectomy)
12/2023 - 07/2020
2Catheters
12/2023 - 08/2020
2Traction
12/2023 - 06/2022
2Length of Stay
12/2023 - 06/2022
2Radiofrequency Ablation
10/2020 - 11/2015
2Oral Medicine
04/2009 - 02/2008
1Operative Time
12/2023
1Vitrectomy
12/2022
1Intravitreal Injections
12/2022
1Sutures (Suture)
06/2022
1Warm Ischemia
06/2022
1Transplantation
12/2020
1Anesthesia
10/2020
1Decompression
08/2020
1Solid-State Lasers
08/2020
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020
1Aftercare (After-Treatment)
11/2018